NCT00810381View on ClinicalTrials.gov

Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

June 30, 1999

Study Completion Date

June 30, 1999

Conditions
Glaucoma
Interventions
DRUG

Nitroglycerin

intravenous infusion; 0, 0.125, 0.25, 0.5, 1 and 2 µg/kg/min; 20 minutes per infusion step

DRUG

Isosorbide-Dinitrate

intravenous infusion; 0, 0.5, 1, 2, 4, and 6 µg/kg/min; 20 minutes per infusion step

DRUG

Sodium-nitroprusside

intravenous infusion; 0, 0.25, 0.5, 1, 2, and 4 µg/kg/min; 20 minutes per infusion step

DRUG

Physiologic saline solution (control substance)

intravenous infusion, infusion period 120 minutes

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00810381 - Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects | Biotech Hunter | Biotech Hunter